Efficacy and Safety of HB-1 for Panic Disorder

Clinical trial NCT06483789 · SUSPENDED

Trial details

NCT number: NCT06483789
Sponsor: HB BioTech, LLC
Status: SUSPENDED
Phase: Phase 2
Study type: INTERVENTIONAL

Panic Disorder Mental Illness

Start date: 2024-10-29
Primary completion: 2027-01-01
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.